Stock 000952 HUBEI GUANGJI PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Hubei Guangji Pharmaceutical Co., Ltd.

Equities

000952

CNE0000010R5

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 16/05/2024 BST 		5-day change 1st Jan Change
6.22 CNY -2.05% Intraday chart for Hubei Guangji Pharmaceutical Co., Ltd. -13.85% -22.15%
04-25 Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-25 Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Hubei Guangji Pharmaceutical Co., Ltd. is the Chinese leader of pharmaceutical ingredients production. The group's activity is organized around four product families:

- vitamins: riboflavin and beta carotene;

- food supplements;

- fine chemistry products;

- medicinal preparations.

Number of employees: 1,256

Sales per Business

CNY in Million2022Weight2023Weight Delta
Raw Material
64.3 %
532 66.7 % 474 64.3 % -10.82%
Preparation
24.0 %
131 16.5 % 177 24.0 % +34.67%
Others
10.7 %
131 16.5 % 79 10.7 % -40.08%
Other Business
1.0 %
3 0.3 % 8 1.0 % +176.27%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
75.3 %
581 72.8 % 556 75.3 % -4.33%
Abroad
24.7 %
217 27.2 % 182 24.7 % -15.99%

Managers

Managers TitleAgeSince
Shu Ruan CEO
 Chief Executive Officer 48 21/04/21
Ming Feng Hu DFI
 Director of Finance/CFO 54 13/09/16
Zheng Dong Lu CTO
 Chief Tech/Sci/R&D Officer 47 -
Bin Zheng BRD
 Director/Board Member 35 21/06/20
Shao Zhi Guo BRD
 Director/Board Member 55 05/01/15
Zhong Yi Ruan PRN
 Corporate Officer/Principal 60 -

Members of the board

Members of the board TitleAgeSince
Qing Yuan Li BRD
 Director/Board Member 47 21/04/21
Shao Zhi Guo BRD
 Director/Board Member 55 05/01/15
Zhong Yi Ruan PRN
 Corporate Officer/Principal 60 -
Ming Feng Hu DFI
 Director of Finance/CFO 54 13/09/16
Bin Zheng BRD
 Director/Board Member 35 21/06/20
Tao Jiang BRD
 Director/Board Member 48 23/01/18
Shu Ruan CEO
 Chief Executive Officer 48 21/04/21
Bo Liu BRD
 Director/Board Member 48 21/04/21
Kui Hong BRD
 Director/Board Member 58 21/04/21
Jian Ming Mei BRD
 Director/Board Member 52 21/04/21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 353,860,939 228,704,998 ( 64.63 %) 9,861,000 ( 2.787 %) 64.63 %

Shareholders

NameEquities%Valuation
Cinda Fund Management Co. Ltd.
2.060 %
6,209,253 2.060 % 5 M ¥
Western Leadbank Fund Management Co., Ltd
0.2692 %
811,400 0.2692 % 661 088 ¥
Bosera Asset Management Co., Ltd.
0.0804 %
242,400 0.0804 % 197 495 ¥
Huatai-PineBridge Fund Management Co., Ltd.
0.0660 %
198,840 0.0660 % 162 005 ¥
China Asset Management Co., Ltd.
0.0287 %
86,600 0.0287 % 70 557 ¥
Everbright PGIM Fund Management Co. Ltd.
0.0265 %
80,000 0.0265 % 65 180 ¥
CITIC-Prudential Fund Management Co., Ltd.
0.0232 %
70,000 0.0232 % 57 033 ¥
Jyah Asset Management Co. Ltd.
0.0126 %
37,900 0.0126 % 30 879 ¥
Da Cheng Fund Management Co., Ltd.
0.006768 %
20,400 0.006768 % 16 621 ¥
Fullgoal Fund Management Co., Ltd.
0.001825 %
5,500 0.001825 % 4 481 ¥

Company contact information

Hubei Guangji Pharmaceutical Co., Ltd.

1 Jiangdi Road Wuxue

435400, Huanggang

+86 71 3621 9458

http://www.guangjipharm.com
address Hubei Guangji Pharmaceutical Co., Ltd.(000952)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
HUBEI GUANGJI PHARMACEUTICAL CO., LTD. Stock Hubei Guangji Pharmaceutical Co., Ltd.
-22.15% 311M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.09% 694B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 593B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.34% 371B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 331B
ABBVIE INC. Stock AbbVie Inc.
+7.39% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 209B
NOVARTIS AG Stock Novartis AG
+10.02% 209B
AMGEN INC. Stock Amgen Inc.
+8.49% 169B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 000952 Stock
  4. Company Hubei Guangji Pharmaceutical Co., Ltd.